[go: up one dir, main page]

AU2745497A - Compositions for use in embolizing blood vessels - Google Patents

Compositions for use in embolizing blood vessels

Info

Publication number
AU2745497A
AU2745497A AU27454/97A AU2745497A AU2745497A AU 2745497 A AU2745497 A AU 2745497A AU 27454/97 A AU27454/97 A AU 27454/97A AU 2745497 A AU2745497 A AU 2745497A AU 2745497 A AU2745497 A AU 2745497A
Authority
AU
Australia
Prior art keywords
compositions
blood vessels
embolizing blood
copolymers
polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU27454/97A
Inventor
Scott Evans
Richard J. Greff
James I. Wright
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Micro Therapeutics Inc
Original Assignee
Micro Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Micro Therapeutics Inc filed Critical Micro Therapeutics Inc
Publication of AU2745497A publication Critical patent/AU2745497A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

Disclosed are compositions suitable for use in embolizing blood vessels which compositions comprise a polymer, a biocompatible solvent and a contrast agent. The polymer is selected from the group consisting of polyacrylonitrile, polyurethane, polyvinylacetate, cellulose acetate butyrate, nitrocellulose and copolymers of urethane/carbonate and copolymers of styrene/maleic acid.
AU27454/97A 1996-05-31 1997-04-25 Compositions for use in embolizing blood vessels Abandoned AU2745497A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US65582296A 1996-05-31 1996-05-31
US08655822 1996-05-31
US80225297A 1997-02-19 1997-02-19
US08802252 1997-02-19
PCT/US1997/007055 WO1997045131A1 (en) 1996-05-31 1997-04-25 Compositions for use in embolizing blood vessels

Publications (1)

Publication Number Publication Date
AU2745497A true AU2745497A (en) 1998-01-05

Family

ID=27097047

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27454/97A Abandoned AU2745497A (en) 1996-05-31 1997-04-25 Compositions for use in embolizing blood vessels

Country Status (8)

Country Link
US (6) US6342202B1 (en)
EP (1) EP0928195B1 (en)
JP (1) JP2001509133A (en)
AT (1) ATE230269T1 (en)
AU (1) AU2745497A (en)
CA (1) CA2252718A1 (en)
DE (1) DE69718180T2 (en)
WO (1) WO1997045131A1 (en)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE230269T1 (en) * 1996-05-31 2003-01-15 Micro Therapeutics Inc COMPOSITIONS FOR USE IN EMBOLIZING BLOOD VESSELS
US7063532B1 (en) 1997-06-20 2006-06-20 Align Technology, Inc. Subdividing a digital dentition model
US6569417B2 (en) * 1997-10-10 2003-05-27 Micro Therapeutics, Inc. Methods for treating urinary incontinence in mammals
US6146373A (en) * 1997-10-17 2000-11-14 Micro Therapeutics, Inc. Catheter system and method for injection of a liquid embolic composition and a solidification agent
US6511468B1 (en) 1997-10-17 2003-01-28 Micro Therapeutics, Inc. Device and method for controlling injection of liquid embolic composition
US6015541A (en) * 1997-11-03 2000-01-18 Micro Therapeutics, Inc. Radioactive embolizing compositions
US6059766A (en) 1998-02-27 2000-05-09 Micro Therapeutics, Inc. Gynecologic embolotherapy methods
US6113629A (en) * 1998-05-01 2000-09-05 Micrus Corporation Hydrogel for the therapeutic treatment of aneurysms
CN1230131C (en) * 1998-11-13 2005-12-07 生物相容英国有限公司 Therapeutic use of polymers
US6595910B2 (en) 1998-12-11 2003-07-22 Scimed Life Systems, Inc. Method for treating fecal incontinence
US6251064B1 (en) 1998-12-11 2001-06-26 Enteric Medical Technologies, Inc. Method for creating valve-like mechanism in natural body passageway
US7132582B2 (en) 2003-05-30 2006-11-07 Council Of Scientific And Industrial Research Catalytic process for the preparation of isolongifolene
ES2252998T3 (en) * 1998-12-11 2006-05-16 Boston Scientific Limited DIGESTIVE TUBE TREATMENT AND KIT FOR IT.
US6238335B1 (en) 1998-12-11 2001-05-29 Enteric Medical Technologies, Inc. Method for treating gastroesophageal reflux disease and apparatus for use therewith
AU6058000A (en) * 1999-07-12 2001-01-30 Scimed Life Systems, Inc. Liquid based vaso-occlusive compositions
US6358197B1 (en) 1999-08-13 2002-03-19 Enteric Medical Technologies, Inc. Apparatus for forming implants in gastrointestinal tract and kit for use therewith
US6540789B1 (en) 2000-06-15 2003-04-01 Scimed Life Systems, Inc. Method for treating morbid obesity
US6855154B2 (en) 2000-08-11 2005-02-15 University Of Louisville Research Foundation, Inc. Endovascular aneurysm treatment device and method
US7294137B2 (en) * 2001-03-27 2007-11-13 Boston Scientific Scimed Device for multi-modal treatment of vascular lesions
US20030004533A1 (en) * 2001-05-04 2003-01-02 Concentric Medical Bioactive polymer vaso-occlusive device
US7687053B2 (en) * 2001-08-20 2010-03-30 Boston Scientific Scimed, Inc. Embolic compositions with non-cyanoacrylate rheology modifying agents
DK1380263T3 (en) * 2002-07-12 2007-12-27 Mycrona Ges Fuer Innovative Me Method and apparatus for determining the actual position of a survey object
WO2004028569A1 (en) * 2002-09-25 2004-04-08 Biocompatibles Uk Limited Polymer compositions for administration to animals
WO2004035022A2 (en) * 2002-10-15 2004-04-29 Microtherapeutics, Inc. Prepolymeric materials for site specific delivery to the body
AU2003295963B2 (en) 2002-11-25 2009-09-03 Boston Scientific Limited Injection device for treating mammalian body
US20040161466A1 (en) 2003-02-14 2004-08-19 Biocompatibles Uk Limited Chemoembolisation
CA2510678A1 (en) * 2003-03-07 2004-09-23 Microtherapeutics, Inc. Compositions for use in embolizing blood vessels comprising high levels of contrast agent
US7651513B2 (en) * 2003-04-03 2010-01-26 Boston Scientific Scimed, Inc. Flexible embolic device delivery system
US8048407B2 (en) * 2003-04-24 2011-11-01 Brent Vernon In situ gelling self-reactive materials for embolization
AU2004275878B2 (en) 2003-09-25 2011-04-14 Rutgers, The State University Inherently radiopaque polymeric products for embolotherapy
US20050090804A1 (en) * 2003-10-22 2005-04-28 Trivascular, Inc. Endoluminal prosthesis endoleak management
WO2005067990A1 (en) * 2004-01-07 2005-07-28 Boston Scientific Santa Rosa Corporation Methods, compositions, and devices for embolizing body lumens
BRPI0502442B1 (en) * 2004-06-28 2015-09-08 Degudent Gmbh opaque dental ceramics, and its preparation process
US8814567B2 (en) * 2005-05-26 2014-08-26 Zimmer Dental, Inc. Dental implant prosthetic device with improved osseointegration and esthetic features
US8377091B2 (en) 2006-06-15 2013-02-19 Microvention, Inc. Embolization device constructed from expansile polymer
WO2008023388A1 (en) 2006-08-23 2008-02-28 Budhaditya Chattopadhyay An apparatus for purificatiion of blood and a process thereof
US8262626B2 (en) 2007-10-23 2012-09-11 Boston Scientific Scimed, Inc. Apparatus and method for treating tissue
AU2008345590B2 (en) 2007-12-21 2014-10-30 Microvention, Inc. Hydrogel filaments for biomedical uses
CN102015012A (en) * 2008-02-29 2011-04-13 普拉罗美德公司 Local embolization by heating thermosensitive polymers
EP2254651A4 (en) * 2008-02-29 2013-03-06 Pluromed Inc Local embolization using thermosensitive polymers
EP2268290B1 (en) * 2008-03-11 2013-01-30 Sujoy Kumar Guha Styrene maleic anhydride based formulation for male contraception and prostate cancer
US9107668B2 (en) * 2008-03-25 2015-08-18 Cook Medical Technologies Llc Embolic particle mixing syringe
US8562348B2 (en) * 2008-07-02 2013-10-22 Zimmer Dental, Inc. Modular implant with secured porous portion
CN102186526B (en) 2008-08-19 2013-10-30 泰科保健集团有限合伙公司 Detachable tip microcatheter
US20100114314A1 (en) * 2008-11-06 2010-05-06 Matthew Lomicka Expandable bone implant
EP2424775B1 (en) 2009-04-30 2016-02-10 Technip France Spar mooring line sharing method and system
US9707058B2 (en) 2009-07-10 2017-07-18 Zimmer Dental, Inc. Patient-specific implants with improved osseointegration
US9993252B2 (en) 2009-10-26 2018-06-12 Microvention, Inc. Embolization device constructed from expansile polymer
US10398444B2 (en) 2011-03-30 2019-09-03 Noha, Llc Advanced endovascular clip and method of using same
US10028745B2 (en) 2011-03-30 2018-07-24 Noha, Llc Advanced endovascular clip and method of using same
US9456823B2 (en) 2011-04-18 2016-10-04 Terumo Corporation Embolic devices
US9011884B2 (en) 2012-04-18 2015-04-21 Microvention, Inc. Embolic devices
JP6480327B2 (en) 2012-06-14 2019-03-06 マイクロベンション インコーポレイテッドＭｉｃｒｏｖｅｎｔｉｏｎ， Ｉｎｃ． Polymer therapeutic composition
US10124087B2 (en) 2012-06-19 2018-11-13 Covidien Lp Detachable coupling for catheter
JP6385937B2 (en) 2012-10-15 2018-09-05 マイクロベンション インコーポレイテッドＭｉｃｒｏｖｅｎｔｉｏｎ， Ｉｎｃ． Polymeric therapeutic composition
CN116333348A (en) * 2013-10-17 2023-06-27 伊莱恩·莱斯纳 Compositions and methods involving occlusive polymer hydrogels
US10124090B2 (en) 2014-04-03 2018-11-13 Terumo Corporation Embolic devices
JP6599361B2 (en) 2014-04-29 2019-10-30 マイクロベンション インコーポレイテッド Polymer containing an active agent
WO2015167751A1 (en) 2014-04-29 2015-11-05 Microvention, Inc. Polymers
JP6149871B2 (en) * 2015-01-15 2017-06-21 日本精工株式会社 Bearing with wireless sensor
WO2016201250A1 (en) 2015-06-11 2016-12-15 Microvention, Inc. Expansile device for implantation
WO2017083753A1 (en) 2015-11-12 2017-05-18 Herr John C Compositions and methods for vas-occlusive contraception and reversal thereof
US10368874B2 (en) 2016-08-26 2019-08-06 Microvention, Inc. Embolic compositions
US12383421B2 (en) 2017-01-05 2025-08-12 Contraline, Inc. Contraceptive devices
CN110381854A (en) 2017-01-05 2019-10-25 考恩特兰有限公司 Methods for implanting and reversing stimulus-responsive implants
WO2018183624A1 (en) 2017-03-29 2018-10-04 The Regents Of The University Of Colorado, A Body Corporate Reverse thermal gels and their use as vascular embolic repair agents
JP7362598B2 (en) 2017-10-09 2023-10-17 マイクロベンション インコーポレイテッド radioactive liquid embolic material
WO2020102234A1 (en) 2018-11-13 2020-05-22 Contraline, Inc. Systems and methods for delivering biomaterials

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3527224A (en) 1967-09-05 1970-09-08 American Cyanamid Co Method of surgically bonding tissue together
US3591676A (en) 1968-11-01 1971-07-06 Eastman Kodak Co Surgical adhesive compositions
US4078124A (en) * 1969-10-09 1978-03-07 Exxon Research & Engineering Co. Laminated non-woven sheet
US4079124A (en) 1976-04-21 1978-03-14 Medi-Physics, Inc. Method of preparing X-ray contrast media containing ores of hafnium, tantalum and tungsten
CA1225585A (en) * 1983-06-30 1987-08-18 Maria T. Litvinova Composition for embolization of blood vessels
US4631188A (en) 1983-08-31 1986-12-23 S.K.Y. Polymers, Ltd. (Kingston Technologies) Injectable physiologically-acceptable polymeric composition
EP0153407B1 (en) * 1983-08-31 1993-03-03 S.K.Y. Polymers Ltd. Injectable physiologically acceptable polymeric compositions
US4847065A (en) * 1987-02-10 1989-07-11 Akimova Alla Y Composition for occlusion of ducts and cavities of human body
US4795741A (en) 1987-05-06 1989-01-03 Biomatrix, Inc. Compositions for therapeutic percutaneous embolization and the use thereof
DE3717871C3 (en) * 1987-05-27 1995-05-04 Georg Prof Dr Schloendorff Method and device for reproducible visual representation of a surgical intervention
JPH02503519A (en) * 1987-05-27 1990-10-25 サージカル　ナビゲーション　テクノロジース　インコーポレーティッド（アン　アフィリエイティッド　カンパニー　オブ　ソファマー　ダンネク　グループ　インコーポレーティッド） Method and apparatus for reproducibly optically displaying surgical procedures
US5213788A (en) * 1988-09-29 1993-05-25 Ranney David F Physically and chemically stabilized polyatomic clusters for magnetic resonance image and spectral enhancement
US4938763B1 (en) 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
US4938961A (en) * 1989-04-28 1990-07-03 Geoffrey Collins Organ preservation solution containing pokyethylene gycol and method of performing cardioplegia
JPH03252799A (en) 1990-03-01 1991-11-12 Kajima Corp Illegal parking/stopping managing device
JPH0455273A (en) 1990-06-22 1992-02-21 Mitsubishi Electric Corp elevator control device
DE69114782T2 (en) 1990-08-08 1996-04-18 Takeda Chemical Industries Ltd Intravascular embolizing agent containing an angiogenesis inhibitor.
GB9026588D0 (en) 1990-12-06 1991-04-24 Marconi Gec Ltd Improvements relating to optical sensing systems
JP2736339B2 (en) 1992-09-30 1998-04-02 株式会社日本感光色素研究所 Liquid embolic material for aneurysms
US5443454A (en) 1992-12-09 1995-08-22 Terumo Kabushiki Kaisha Catheter for embolectomy
JP2535785B2 (en) * 1994-06-03 1996-09-18 工業技術院長 Vascular embolic agent
US5580568A (en) 1995-07-27 1996-12-03 Micro Therapeutics, Inc. Cellulose diacetate compositions for use in embolizing blood vessels
US5667767A (en) 1995-07-27 1997-09-16 Micro Therapeutics, Inc. Compositions for use in embolizing blood vessels
ES2194110T3 (en) * 1995-07-27 2003-11-16 Micro Therapeutics Inc NEW EMBOLIZING COMPOSITIONS.
US5702361A (en) * 1996-01-31 1997-12-30 Micro Therapeutics, Inc. Method for embolizing blood vessels
US6103254A (en) * 1996-05-31 2000-08-15 Micro Therapeutics, Inc. Methods for sterilizing male mammals
ATE230269T1 (en) 1996-05-31 2003-01-15 Micro Therapeutics Inc COMPOSITIONS FOR USE IN EMBOLIZING BLOOD VESSELS
US5695480A (en) 1996-07-29 1997-12-09 Micro Therapeutics, Inc. Embolizing compositions
DE69835422T2 (en) * 1998-01-22 2006-12-21 Biosense Webster, Inc., Diamond Bar MEASUREMENT IN THE BODY'S INSIDE
JP3252799B2 (en) 1998-06-25 2002-02-04 日本電気株式会社 Input power control circuit
US6531111B1 (en) * 1999-05-21 2003-03-11 Micro Therapeutics, Inc. High viscosity embolizing compositions

Also Published As

Publication number Publication date
US20030185758A1 (en) 2003-10-02
US6342202B1 (en) 2002-01-29
US20030003056A1 (en) 2003-01-02
EP0928195B1 (en) 2003-01-02
US6858219B2 (en) 2005-02-22
DE69718180D1 (en) 2003-02-06
US20010024637A1 (en) 2001-09-27
US7138106B2 (en) 2006-11-21
DE69718180T2 (en) 2003-08-21
EP0928195A1 (en) 1999-07-14
US20020076381A1 (en) 2002-06-20
US6756031B2 (en) 2004-06-29
US20020187102A1 (en) 2002-12-12
WO1997045131A1 (en) 1997-12-04
ATE230269T1 (en) 2003-01-15
JP2001509133A (en) 2001-07-10
CA2252718A1 (en) 1997-12-04

Similar Documents

Publication Publication Date Title
AU2745497A (en) Compositions for use in embolizing blood vessels
AU6639796A (en) Cellulose diacetate compositions for use in embolizing blood vessels
AU6604296A (en) Novel compositions for use in embolizing blood vessels
CA2267244A1 (en) Methods for treating urinary incontinence in mammals
AU3519297A (en) Phenyl-substituted alkenylcarboxylic acid guanidides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
CA2270599A1 (en) Chemical modification of biomedical materials with genipin
CA2047944A1 (en) Process for preparing pharmaceutical compositions having an increased active substance dissolution rate, and the compositions obtained
CA2159055A1 (en) Compositions containing polyanionic polysaccharides and hydrophobic bioabsorbable polymers
WO1996040055A3 (en) Biological agent compositions
CA2231471A1 (en) A delivery system for intraluminal vascular grafts
AU5795494A (en) Biocompatible monomer and polymer compositions
AU4867697A (en) Oxadiazoles, processes for preparing them and their use as pharmaceutical compositions
AU4376089A (en) Improved retainer for surgical sutures
AU7017596A (en) Combined tissue clamping and suturing instrument
AU8679198A (en) Modified polylactide compositions, water-responsive, biodegradable films and fibers comprising polylactide and poly(vinyl alcohol) and methods for making the same
AU5025696A (en) Urinary bladder submucosa derived tissue graft
CA2172513A1 (en) Aminocyclohexylesters and uses thereof
AU3308297A (en) Stable aquenous dispertions of cellulose esters, method of making and their use in coatings
CA2230595A1 (en) Bioresorbable polymer use in cochlear and other implants
AU1414397A (en) Process for preparing blends of poly(ethylene terephthalate) and poly(ethylene 2,6-naphthalenedicarboxylate)
AU3976297A (en) Intraluminal delivery of tissue lysing medium
AU8119391A (en) Hemostatic stent
AU2745297A (en) Methods for sterilizing male mammals
AU4717096A (en) Solid active agent preparations containing hydroxypropyl cellulose
AU3781899A (en) Starch degradation/graft polymerisation composition, process, and uses thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase